EUCTR2009-018085-35-DK进行中（未招募）1 期
Intestinal Inflammation in Ankylosing Spondylitis assessed by Fecal Calprotectin, Capsular Endoscopy and Colonoscopy and the effects of Adalimumab on mucosal healing - INTASAH
Regionalhospital Silkeborg0 个研究点开始时间: 2010年5月5日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients (>18 years and =45 years) with axial SpA according to the ASAS criteria
- •Active SpA assessed by physician.
- •BASDAI = 4.
- •Faecal calprotectin = 100mg/kg.
- •Negative pregnancy test (serum-HCG) for women of childbearing age before the start of the study. (Women not of childbearing age are defined as postmenopausal for at least 1 year or surgically sterilised (bilateral tubal ligation, bilateral oophorectomy or hysterectomy)). Women of childbearing age included in the study will be required to use contraception during the entire study period (i.e. one of the following: contraceptive pills, intrauterine device, depot injection of gestagen, subdermal implant, hormonal vaginal ring or transdermal patch). In addition, contraception must be used following any discontinuation of the study drug for a period of 150 days.
- •Ability and willingness to self-administer the subcutaneous injections or have a person available to administer the injections.
- •Ability and willingness to give written informed consent and meet the requirements of the study protocol.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diagnosed inflammatory bowel disease or high risk of intestinal stricture (previous abdominal stricture, radiation of abdomen, major abdominal surgery).
- •NSAID ingestion less than 4 weeks before inclusion.
- •Persons with latent TB (positive Mantoux skin test (>10 mm), positive cultivation for mycobacteria in tissue samples and/or chest X-ray indicating TB) or other risk factors for activation of untreated latent TB.
- •Current or recurrent infections or serious infections requiring hospitalisation or treatment with intravenous antibiotics within the last 30 days or oral antibiotics within the last 14 days before inclusion.
- •Positive serology for Hepatitis B or C indicating active infection.
- •Medical history of positive HIV status (in case of suspicion control of HIV test).
- •Medical history of histoplasmosis or listeriosis.
- •Previous cancer or lymphoid proliferative disease except completely well-treated cutaneous squamous cell carcinoma, basal cell carcinoma or cervical dysplasia.
- •Previous diagnosis or signs of demyelinising diseases of the central nervous system (e.g. opticus neuritis, disturbance of vision, disturbed gait/ataxia, facial paresis, apraxia).Severe renal insufficiency (creatinine clearance < 35 ml/min - normogram).
- •Affected hepatic function: Liver enzymes > 3 x above the normal limit.
- •Clinically significant drug or alcohol abuse in the last year or daily current alcohol consumption.
- •Diabetes, unstable ischemic heart disease, heart failure (NYHA III-IV), active chronic inflammatory bowel disease, recent apoplexia cerebri (within 3 months), chronic leg ulcer and any other condition (e.g. indwelling catheter) which at the discretion of the investigator means that participation in the protocol would entail a risk for the person in question.
- •Anticoagulant treatment.
- •Pregnancy or breast-feeding.
- •Other inflammatory rheumatologic diseases that cannot be related to spondyloarthritis
- •Current parvovirus B 19 infection.
- •Glucocorticosteroid treatment within the last 4 weeks (except nasal and inhalation steroids). Contraindication to study drug.
研究者
相似试验
已完成
4 期
Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal HealingSpondyloarthritisEnterocolitisNCT01174186Regionshospitalet Silkeborg30
招募中
不适用
Cardiac disease in Ankylosing SpondylitisAnkylosing spondylitis, osteoartritisNL-OMON25008Reade192
已完成
不适用
Sensitive Imaging in Ankylosing SpondylitisBechterew disease100836241000381610043237Ankylosing SpondylitisNL-OMON39151eids Universitair Medisch Centrum40
Unknown
早期 1 期
The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients.Ankylosing SpondylitisNCT03726645Hospital District of Helsinki and Uusimaa20
尚未招募
不适用
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University HospitalInflammatory Bowel Disease (IBD)SpondylarthropathiesTNF-alpha InhibitorsNCT06601595Mohamed Nasr100